Fintel reports that on January 20, 2026, BTIG initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Buy recommendation.

Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, ...

Dublin City University’s (DCU) faculties of Science and Health and Engineering and Computing marked a strong presence at the ...

Breeding pedigree Limousin cattle under the Carrowreagh prefix since 1988, Pat Bruen is one of Ireland’s most-established ...

The latest fair value estimate for Myriad Genetics has shifted only slightly, now at US$8.32 compared with US$8.52 before, ...

Sharma’s focus has narrowed to a simpler equation: how many good years that wealth can actually buy, and whether Indians are ...

Women neurologists of various subspecialties and career stages gathered for the 4th Annual Women in Neurology Conference, hosted by the Women Neurologists Group.

But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have ...

Turkey became a global hotspot for hair restoration for a reason: experienced teams, modern clinics, and a well-built medical ...

But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look ...

In 2025, Brazil recorded another pork export year. Shipments closed the year at a record 1.51 million tons, up 11.6% from ...